Tobacco and Aboriginal people in NSW

Rowena G. Ivers

doi:10.1071/NB07123

RESEARCH ARTICLE

Previous Next Contents Vol 19(4)

Tobacco and Aboriginal people in NSW

Rowena G. Ivers

+ Author Affiliations

- Author Affiliations

^A Illawarra Aboriginal Medical Service

^B Email: rowenaivers@bigpond.com

NSW Public Health Bulletin 19(4) 65-67 https://doi.org/10.1071/NB07123
Published: 29 April 2008

Abstract

Tobacco use is a major cause of morbidity and mortality for Aboriginal people in NSW. Few interventions to reduce the harm resulting from tobacco use have been developed specifically for this population. However, brief interventions for smoking cessation, pharmacotherapies such as nicotine replacement therapy, bupropion and varenicline, quit groups and interventions aimed at reducing smoking by pregnant women and hospital inpatients are likely to be effective. Broader population interventions such as anti-tobacco advertising, price rises for tobacco products and prevention of sales to minors are also likely to be effective in reducing the harm resulting from tobacco use.

References

[1] Commonwealth of Australia 2006 National Aboriginal and Torres Strait Islander Health Survey Australia 2004–05. ABS Catalogue No. 4715.0. Canberra: Commonwealth of Australia.

[2] Centre for Epidemiology and Research. 2006 Report on Adult Health from the New South Wales Population Health Survey. Sydney: NSW Department of Health, 2007.

[3] Centre for Epidemiology and Research. 2002–2005 Report on Adult Aboriginal Health from the New South Wales Population Health Survey. Sydney: NSW Department of Health, 2006.

[4] Centre for Epidemiology and Research, NSW Department of Health. New South Wales Mothers and Babies 2005. N S W Public Health Bull 2007; 18 1–137.

[5] Cunningham J, Condon JR. Premature mortality in Aboriginal adults in the Northern Territory, 1979–1991. Med J Aust 1996; 165 309–12.
| PubMed |

[6] McLennan W, Madden R. The Health and Welfare of Australia’s Aboriginal and Torres Strait Islander Peoples. Canberra: Australian Bureau of Statistics, 1997.

[7] NSW Health. Tobacco Action Plan NSW: 2005–9. Sydney: NSW Health, 2006. Available at http://www.health.nsw.gov.au/pubs/2005/pdf/tobacco_ap_bground.pdf (accessed 18.6.07).

[8] Ivers RG. A review of tobacco interventions for Indigenous Australians. Aust N Z J Public Health 2003; 27(3): 294–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[9] Ivers RG. An evidence-based approach to planning tobacco interventions for Aboriginal people, 2004. Drug Alcohol Rev 2004; 23(1): 5–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[10] Silagy C, Ketteridge S. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 1996;: CD000165.
| Crossref | GoogleScholarGoogle Scholar |

[11] Rice V, Stead L. Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews 1999;: CD001188.

[12] Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2005;: CD001292.

[13] Silagy C, Mant D, Fowler G, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2008;: CD000146.

[14] Ivers RG, Farrington M, Burns CB, Bailie RS, D’Abbs PH, Richmond RL, et al. A study of the use of free nicotine patches by Indigenous people. Aust N Z J Public Health 2003; 27(5): 486–90.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[15] Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Vareniciline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist vs sustained release bupropion and placebo for smoking cessation. JAMA 2006; 296 47–55.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[16] Jorenby DE, Taylor Hays J, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. Efficacy of vareniciline, an alpha4beta2 nicotinic aacetylcholine receptor partial agonist vs placebo or sustained release bupropion for smoking cessation. JAMA 2006; 296 56–63.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[17] Lumley J, Oliver S, Waters E. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 1998;: CD001055.

[18] Coleman T, Britton J, Thornton J. Nicotine replacement therapy in pregnancy is probably safer than smoking. BMJ 2004; 328(7446): 965–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[19] Rigotti N, Munafo M, Murphy M, Stead L. Interventions for smoking cessation in hospitalised patients. Cochrane Database of Systematic Reviews 2001;: CD001837.

[20] Wolfendon L, Freund M, Campbell E, Wiggers J, Paul C, Mitchell E. Managing nicotine dependence in NSW hospital patients. N S W Public Health Bull 2004; 15(5–6): 98–101.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[21] Sowden A, Arblaster L. Mass media interventions for preventing smoking in young. Cochrane Database of Systematic Reviews 1998;: CD001006.

[22] Ivers R, Castro A, Parfitt D, Bailie RS, Richmond RL, D’Abbs PH. Television and delivery of health promotion programs to remote Aboriginal communities. Health Promot J Austr 2005; 16(2): 155–8.
| PubMed |

[23] Stead L, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005;: CD001007.

[24] Stead L, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 2001;: CD002850.

[25] Australian Medical Association and Australian Pharmaceutical Manufacturer’s Association. Indigenous smoking: issues and responses. Canberra: Australian Medical Association and Australian Pharmaceutical Manufacturer’s Association, 2000.

[26] Corti B, Holman C, Donovan R, Frizzell S, Carroll A. Using sponsorship to create healthy environments for sport, racing and arts venues in Western Australia. Health Promot Int 1995; 10(3): 185–97.
| Crossref | GoogleScholarGoogle Scholar |

[27] Lancaster T, Stead L. Self-help interventions for smoking cessation. Cochrane Database of Systematic Reviews 1998;: CD001118.

[28] O’Connor M, Parker E, Mieklejohn B, Oldenburg B, Alati R. Heart Health education resources for Aboriginal and Torres Strait Islander communities: The Health Worker’s view. Aborig Isl Health Work J 1999; 23(2): 20–3.

[29] Contributors to the Cochrane Collaboration and the Campbell Collaboration. Evidence from systematic reviews of research relevant to implementing the ‘wider public health’ agenda. In National Health Service Centre for Reviews and Dissemination; 2000.

[30] Manley M, Lynn W, Payne Epps R, Grande D, Glynn T, Shopland D. The American Stop Smoking Intervention Study for cancer prevention: an overview. Tob Control 1997; 6 S5–11.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[31] Serra C, Cabezas C, Bonfill X, Pladevall-Vila M. Interventions for preventing tobacco smoking in public places. Cochrane Database of Systematic Reviews 2000;: CD001294.
| Crossref | GoogleScholarGoogle Scholar |

[32] Health NSW. NSW Smoke-free Environment Amendment Act 2004. Available at: http://www.health.nsw.gov.au/public-health/health-promotion/tobacco/sfeaa2004.html. Accessed 18 June 2007.

[33] Stead L, Lancaster T. Interventions for preventing tobacco sales to minors. 1999 1999;: CD001497.
| Crossref | GoogleScholarGoogle Scholar |